Skip to content

Last updated

Reviewed against published research RSS

Skin Concerns

Hyperpigmentation and Melasma: Why Dark Spots Form

Why melasma, sun spots and post-acne marks form, how melanin ends up in the wrong place, what treatments show, and why sun and visible light matter.

Close-up of a freckled face with the eye closed and strands of hair across it
Fig. 1 Freckles and sun spots both reflect extra melanin. Melasma is also linked to visible light, hormones and genetics, and it often returns after treatment. Photograph: Chermiti Mohamed / Unsplash

Dark spots are among the most common reasons people buy skin care, and also among the most frustrating to treat. Part of the difficulty is that "dark spot" covers several different conditions. A sun spot, a mark left by a pimple and a patch of melasma can look alike, but they form in different ways and respond differently to treatment.

What hyperpigmentation is

Hyperpigmentation means an area of skin that is darker than the skin around it. The color comes from melanin, the pigment made by melanocytes. The American Academy of Dermatology (AAD) describes melanocytes as the cells that give skin its color.

Darkening happens in two broad ways. Melanocytes can make more melanin than usual, or melanin can be deposited in the wrong layer of skin. Which of these is happening affects how a spot looks and how stubborn it is.

The three most common types

Table 1. The three most common types
Type Main trigger Typical look Usual course
Solar lentigo (sun spot) Long-term UV exposure Flat, well-defined, evenly colored spot on sun-exposed skin Persists year-round; harmless
Postinflammatory hyperpigmentation Acne, eczema, burns, other skin injury Light brown to black patch where the injury was Temporary, but can last longer in darker skin
Melasma Sun and visible light, hormones, genetics Blotchy brown or gray-brown patches on both sides of the face Long-lasting, often returns

How it works

Sun spots

DermNet describes solar lentigines as common, benign, flat spots caused by chronic UV exposure from sunlight, sunbeds or some forms of phototherapy. UV is thought to increase melanin production and how much pigment the skin cells hold on to. The number of melanocytes is normal or only slightly raised.

They appear mostly in middle-aged and older adults and in people with lighter skin, and they are also common on the face in Asian populations. Common sites include the backs of the hands, forearms, upper body and shins.

Marks after acne or injury

DermNet explains that postinflammatory hyperpigmentation can follow almost any injury or inflammation, such as a burn, dermatitis or infection. There are two patterns.

  • Epidermal pigment. Inflammation in the top layer of skin prompts melanocytes to make more melanin and pass it to nearby skin cells. This pigment sits close to the surface.
  • Dermal pigment. When the deepest layer of the epidermis is injured, melanin drops into the dermis below, where immune cells called macrophages trap it. This deeper pigment gives a gray, purple or brown tone.

The marks can occur in anyone but are most common in darker skin, where the color is often more intense and lasts longer. UV exposure can darken them further.

Melasma

The cause of melasma is complex. The AAD notes that melanocytes tend to be more active in people with melasma, though why is not well understood. DermNet describes it as a possible photoaging disorder in people with a genetic predisposition.

Several triggers are linked to it:

  • Light. UV and visible light promote melanin production, according to DermNet. The AAD notes that visible light has been shown to worsen melasma, especially in darker skin tones.
  • Hormones. Pregnancy, birth control pills, hormone-releasing devices and hormone replacement therapy are implicated in about a quarter of affected women, according to DermNet. The British Association of Dermatologists (BAD) notes that up to 50% of pregnant women may be affected.
  • Genetics. DermNet reports that about 60% of patients have affected relatives. The AAD cites a study of 324 patients in which 48% reported a blood relative with melasma.
  • Other factors. Thyroid disease and some medicines that increase sun sensitivity are associated. The AAD describes the evidence on stress as controversial. Indoor tanning can worsen melasma.

Melasma usually begins between ages 20 and 40, is more common in women, and is most common in people with medium skin tones, according to DermNet. The BAD notes there is no evidence that blue light from personal devices affects the skin.

Why depth matters

DermNet classifies melasma by where the pigment sits. Epidermal melasma is well-defined and dark brown and usually responds well to treatment. Dermal melasma is less defined, light brown to blue-gray, and usually responds poorly. Mixed melasma is the most common type and usually improves partly. The same principle applies to postinflammatory marks: topical treatments, peels and lasers can help epidermal pigment but are not effective for dermal pigment.

What treatment involves

Sun protection comes first

The AAD, the BAD and DermNet all treat sun protection as the foundation. For melasma, the AAD recommends daily broad-spectrum sunscreen with SPF 30 or higher, shade and a wide-brimmed hat. It also recommends a tinted sunscreen containing iron oxide, which adds protection against visible light. DermNet recommends SPF 50+ broad-spectrum sunscreen for postinflammatory marks on sun-exposed skin.

Topical treatments

Table 2. Topical treatments
Treatment What the sources report
Hydroquinone Blocks melanin production; prescription only in the US according to the AAD, and prescribed by a doctor in the UK according to the BAD
Triple combination cream Hydroquinone, tretinoin and a corticosteroid; DermNet reports clearing or improvement in 60% to 80% of melasma cases
Azelaic acid, kojic acid, vitamin C Described by the AAD as gentler options
Cysteamine, thiamidol, tranexamic acid cream Listed by DermNet and the BAD as other topical options
Retinoids, glycolic acid peels Used for postinflammatory marks according to DermNet

DermNet notes that combinations are usually needed for significant improvement in postinflammatory hyperpigmentation.

Tranexamic acid

Tranexamic acid is a medicine that blocks plasmin formation. A 2018 meta-analysis in BioMed Research International pooled 21 studies with 1,563 patients. Both oral and topical tranexamic acid used alone reduced melasma severity scores. The authors called it promising but said the evidence was not strong enough for a firm conclusion, citing generally low study quality and wide differences between trials.

The AAD reserves oral tranexamic acid for melasma that is very difficult to treat and advises telling your dermatologist if you have a history of blood clots.

Procedures

Chemical peels, microneedling, lasers and light treatments may be added for stubborn melasma. DermNet cautions that lasers carry a high risk of relapse and of growing resistance to treatment, and that peels and lasers can themselves cause postinflammatory darkening.

Side effects and who should be careful

  • Hydroquinone. The BAD advises using it for only a few weeks at a time because it can irritate skin and over-lighten it. It can occasionally make skin darker and should be avoided in pregnancy.
  • Oral tranexamic acid. The 2018 meta-analysis reported mostly minor side effects, including stomach upset and lighter or less frequent periods. Topical forms caused irritation, dryness and scaling.
  • Irritation in general. The AAD notes that irritation may darken dark spots. It recommends gentle, fragrance-free products and stopping any product that burns or stings.
  • Procedures on darker skin. Because injury can trigger new pigment, peels and lasers need experienced hands, especially in skin that marks easily.
  • Spots that change. DermNet notes that sun spots are harmless but can resemble early melanoma, and that having them is an independent risk factor for melanoma. A spot that is changing or looks unusual should be checked by a dermatologist.

Practical steps

Identify the type

A dermatologist can usually tell the types apart by examining the skin, sometimes with a Wood lamp or dermatoscope, according to DermNet. Knowing the type helps set expectations.

Protect daily

Apply broad-spectrum SPF 30 or higher every day and reapply at least every two hours outdoors, as the AAD and BAD advise. For melasma, choose a tinted formula with iron oxide. Avoid tanning beds.

Layer in the right order

The AAD suggests applying melasma medicine first, then sunscreen, then any camouflage makeup.

Expect a long timeline

The AAD notes that melasma treatment usually takes 3 to 12 months to show results, and longer if it has been present for years. Melasma that starts in pregnancy may fade a few months after delivery, but the BAD notes it can return in later pregnancies and often comes back after treatment stops.

The short version

Dark spots form when melanocytes overproduce melanin or when melanin settles deeper in the skin. Sun spots come from years of UV, postinflammatory marks follow acne or injury, and melasma involves light, hormones and genetics. Pigment near the surface responds better than deep pigment. Daily sun protection, including visible-light protection for melasma, is the base of every treatment plan, and patience is part of it.

References

  1. DermNet. Melasma (facial pigmentation). dermnetnz.org/topics/melasma (opens in a new tab)
  2. DermNet. Postinflammatory hyperpigmentation. dermnetnz.org/topics/postinflammatory-hyperpigmentation (opens in a new tab)
  3. DermNet. Solar lentigo. dermnetnz.org/topics/solar-lentigo (opens in a new tab)
  4. American Academy of Dermatology. Melasma: Causes. aad.org/public/diseases/a-z/melasma-causes (opens in a new tab)
  5. American Academy of Dermatology. Melasma: Diagnosis and treatment. aad.org/public/diseases/a-z/melasma-treatment (opens in a new tab)
  6. American Academy of Dermatology. Melasma: Self-care. aad.org/public/diseases/a-z/melasma-self-care (opens in a new tab)
  7. British Association of Dermatologists. Melasma. skinhealthinfo.org.uk/condition/melasma (opens in a new tab)
  8. BioMed Research International (via PMC). Tranexamic Acid for Adults with Melasma: A Systematic Review and Meta-Analysis. pmc.ncbi.nlm.nih.gov/articles/PMC6247725 (opens in a new tab)

Links go to the abstract, full text or reference page. Found an error? See corrections.